The cannabis sector has been booming in Switzerland since 2016 when the country legalized cannabis flowers containing less than 1% THC as a tobacco substitute. Along with the production, further processing and trading of CBD, the production and export of medical cannabis containing over 1% THC will be permitted from the middle of 2022.
Pilot projects are also underway relating to the authorization of cannabis for leisure use and experts are predicting that comprehensive regulation will be achieved within the next three years.
As an addition to the CB Expo (Cannabis Business Expo & Conference) and CannaTrade (business and consumer trade fair), the CB Club is offering a select group the chance to acquire news, insight and new contacts within a refined setting and relaxed atmosphere at one-day networking events.